CLINICAL TRIALS PROFILE FOR NOVAREL
✉ Email this page to a colleague
All Clinical Trials for NOVAREL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05571111 ↗ | Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation | Not yet recruiting | Ferring Pharmaceuticals | Phase 2 | 2022-10-17 | The primary purpose of this trial is to compare three different doses of FE 999302 with 250 µg OVITRELLE and 10,000 IU NOVAREL on oocyte maturity when administered as a single dose for final development of the oocytes in women undergoing controlled ovarian stimulation. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NOVAREL
Condition Name
Clinical Trial Progress for NOVAREL
Clinical Trial Phase
Clinical Trial Sponsors for NOVAREL
Sponsor Name